This inventor holds 1 USPTO granted patent. Top assignee: Sail Biomedicines. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: John Mancuso: Innovator in Pharmaceutical Chemistry
Introduction
John Mancuso is a notable inventor based in Saint-Marthe-sur-le-Lac, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Mancuso holds a patent for "Fused imidazole derivatives as AHR antagonists." This patent relates to compounds of formulae (I)-(VI) and their pharmaceutically acceptable salts. The disclosure includes pharmaceutical compositions comprising these compounds, methods of preparing them, and intermediate compounds useful for their preparation. The invention aims to provide methods for treating or preventing diseases, particularly cancer, and conditions associated with dysregulated immune responses or aberrant AHR signaling.
Career Highlights
John Mancuso is currently associated with Sail Biomedicines, where he applies his expertise in pharmaceutical development. His work focuses on innovative solutions to complex medical challenges, contributing to advancements in cancer treatment and immune response regulation.
Collaborations
Mancuso collaborates with talented professionals in his field, including Alessandra Bartolozzi and John Robert Proudfoot. These collaborations enhance the research and development efforts at Sail Biomedicines.
Conclusion
John Mancuso's work exemplifies the impact of innovative thinking in pharmaceutical chemistry. His contributions through patents and collaborations continue to advance the field and offer hope for improved treatments in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile